#9450
Strongyloïdes
ratti IgG ELISA
ELISA kit for the diagnosis of human strongyloidosis
Lot 2517S (Expiry date : 03.02.2027)
Production date : 04.06.2025
Results of quality control 3 (after
12 months), date: 29.05.2026
No serum blank (average) : 0.140
| Sample |
Absorbances of individual wells after blank reduction |
Average |
% pos. |
No serum blank
|
-0.004 |
-0.003 |
0.002 |
0.005 |
0.000 |
0 |
Negative control serum
(N° 9450-06) |
0.079 |
0.095 |
0.092 |
0.105 |
0.093 |
4 |
Weak positive serum
(N° 9450-07) |
0.744 |
0.733 |
0.791 |
0.762 |
0.758 |
34 |
Positive control serum
(N° 9450-08) |
2.101 |
2.260 |
2.200 |
2.318 |
2.220 |
100 |
Validation criteria:
| |
Criterion |
Measure |
Valid |
| Absorbance of positive serum 9450-08 |
> 1.200 |
2.220 |
Yes |
| Absorbance of weak positive serum 9450-07, as % of positive
serum |
> 18 % |
34 % |
Yes |
| Absorbance of negative serum 9450-06, as % of positive serum |
< 10 % |
4 % |
Yes |
| Absorbance of no serum blank |
< 0.350 |
0.140 |
Yes |
Comments:
Good for use.
Bordier Affinity Products SA, Chatanerie 2,
Bâtiment Biokema,
CH-1023 Crissier, Switzerland
Phone: + 41 21 633 31 67. Fax: +
41 21 633 31 78. Email: cb(at)bordier.ch
|